Opioid Dependence Treatment Market Size & Share, by Drug Cases (Naloxone, Buprenorphine, Methadone); Sales Channel (Retail Pharmacies, Online Pharmacies, Hospitals, Rehabilitation Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4003
  • Published Date: May 01, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Opioid Dependence Treatment Market size is expected to reach USD 7 billion by the end of 2035, growing at a CAGR of 9% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of opioid dependence treatment was USD 3 Billion. The growth of this market is driven by the increasing number of people all over the world getting addicted to opioids. This number has been increasing at a steady pace over the years. According to the World Health Organization (WHO), there were approximately 53 million opioid users worldwide in 2019. This has increased the demand for opioid addiction treatment. 

Moreover, the market is also anticipated to grow with rising government initiatives regarding opioid dependency treatment. The government authorities of various regions across the globe time and again have identified the need for an opioid shortage and have adopted multiple initiatives and programs to promote opioid dependency treatment all over the world. In the United States, the Substance Abuse and Mental Health Services Administration (SAMHSA) has allocated funds to support drug-assisted treatment (MAT) for opioid addiction. 


Opioid Dependence Treatment Market
Get more information on this report: Request Free Sample PDF

Opioid Dependence Treatment Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Number of Cases of Opioid Abuse and Addictions Among People Worldwide – A large amount population is seen suffering from severe or chronic illness nowadays. These patients do intake opioid drugs as a painkiller post their treatment. In many cases, this drug consumption becomes their addiction. According to a survey conducted by the National Drug Dependence Treatment Centre in India and released in February 2019, 3% of Indians are now using opioids, and 0.5% of them are projected to need assistance with their opioid dependence.
  • Favorable Reimbursements for Smoking Cessation Therapy – Supportive reimbursement for smoking cessation therapy is anticipated to drive the growth of the market in the forecast period. Affordable reimbursement for smoking cessation treatment will help ensure that people on opioid addiction treatment have access to the support they need to quit. In many countries, health insurance companies can pay for smoking cessation treatment and counseling for people being treated for opioid dependence. For instance, in the United States, both Medicare and Medicaid cover the cost of smoking cessation counseling and medication for qualified individuals.  
  • Growing Government Initiatives –The government authorities of various regions across the globe time and again have identified the need for the opioid crisis and have adopted multiple initiatives and programs to promote opioid dependency treatment all over the world. In March 2022, HHS announced funding for substance dependence treatment and prevention programs to expand access to medication-assisted treatment for opioid dependence and prevent misutilization of painkillers.
  • Increasing Healthcare Expenditure - Rising healthcare spending, especially in developed countries, is expected to drive the market growth of the opioid addiction treatment market. According to the World Health Organization (WHO), global healthcare spending is expected to reach USD18.28 trillion by 2040, with developed countries accounting for the majority of this spending. This may increase the demand for effective opioid addiction treatment options.  

Challenges

  • Side Effects of Opioid Use Disorder Drugs – Vomiting, bladder pain, abdominal cramps, breathing complications, and diarrhea are some of the side effects of opioid use disorder drugs. And these side effects can pose a limitation on the growth of this market in the upcoming times.
  • High Cost of Treatment
  • Legal and Regulatory Challenges

Opioid Dependence Treatment Market: Key Insights

Base Year

2022

Forecast Year

2023 - 2035

CAGR

~9%

Base Year Market Size (2022)

~USD 3 billion

Forecast Year Market Size (2035)

~USD 7 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Opioid Dependence Treatment Segmentation

Drug Cases (Naloxone, Buprenorphine, Methadone)

The global opioid dependence treatment market is segmented and analyzed for demand and supply by drug cases into naloxone, buprenorphine, and methadone. Out of these, the buprenorphine segment is anticipated to hold the largest market share by the end of 2035. This can be attributed to the high demand for these drugs in the developed market such as the US and France. In the United States, buprenorphine is approved by the Food and Drug Administration (FDA) for the treatment of opioid addiction. In 2019, more than 1.3 million buprenorphine prescriptions were issued in the United States. Moreover, the buprenorphine segment has grown in recent years as more healthcare providers recognize the benefits of MAT or medication-assisted treatment of opioid addiction.

Sales Channel (Retail Pharmacies, Online Pharmacies, Hospitals, Rehabilitation Centers)

The global opioid dependence treatment market is segmented and analyzed for demand and supply by sales channel into retail pharmacies, online pharmacies, hospitals, and rehabilitation centers. Out of these, the hospital segment is anticipated to hold the largest market share by the end of 2035. Treatment for opioid dependence is often given in hospitals, especially for individuals who need inpatient treatment or detoxification. Hospitals can also provide outpatient care and aftercare services to people who have completed inpatient care. This is expected to drive the growth of this segment in the forecast period.

Our in-depth analysis of the global market includes the following segments:

        By Drug Cases

  • Naloxone

  • Buprenorphine

  • Methadone

        By Sales Channel

  • Retail Pharmacies

  • Online Pharmacies

  • Hospitals

  • Rehabilitation Centers

 


Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Opioid Dependence Treatment Industry - Regional Synopsis

APAC Market Statistics

The opioid dependence treatment market in Asia Pacific is estimated to witness noteworthy growth over the forecast period. This can be attributed on the back of the growing awareness among the general population about opioid use disorder, and the large patient pool in the region. According to estimates the prevalence of opioid use disorder in the Asia-Pacific region at 0.3% to 0.6% of the population, with some countries such as Thailand and Myanmar reporting higher rates.  The market growth is fueled by increasing demand for drug-assisted treatment (MAT), which combines pharmacotherapy with counseling and behavioral therapy to help recover from opioid addiction. Several countries in the region have also taken steps to expand access to opioid addiction treatment. In India, for instance, the government has launched a program to provide free opioid replacement therapy (OST) to injecting drug users. In Thailand, the government has set up methadone clinics to provide drug-assisted treatment for opioid addicts. 

North American Market Forecast   

Moreover, the opioid dependence treatment market in North America is expected to acquire the largest share during the forecast period. This can be attributed owing to the increasing number of people suffering from opioid dependency, and the high emphasis of government to tackle the same. As per the U.S. Department of Health and Human Services, in a survey conducted in 2019, 10.1 million people aged 12 years or older misused opioids in 2018, whereas 9.7 million people misused prescribed pain relievers. In addition, high healthcare spending is also projected to boost market growth in the region in the coming years. In addition to MAT, other treatment options for opioid addiction include detox programs, behavioral therapy, and support groups. The market for these treatments is also growing in North America as more people seek help with their opioid addiction. Several countries in North America have also taken steps to expand access to opioid addiction treatment. For example, in the United States, the government has launched initiatives to expand access to his MAT, increase funding for addiction treatment programs, and improve addiction education for providers. Overall, the North American opioid addiction treatment market represents a huge opportunity for healthcare providers and pharmaceutical companies. However, more efforts are needed to tackle the opioid epidemic and improve access to effective, evidence-based treatment options.  

Europe Market Forecast

The opioid dependence treatment market in Europe region is estimated to account for a significant market share in the forecast period. The market is driven by a combination of factors such as the increasing prevalence of opioid dependence, growing awareness of the need for treatment, and favorable reimbursement policies.  Several European countries have also taken steps to expand access to opioid addiction treatment. For instance, in the UK, the government has launched an initiative to expand access to naloxone, a drug used to curb opioid overdoses. In Germany, the government has established a program to provide opioid replacement therapy (OST) for people with opioid dependence. Overall, the European opioid addiction treatment market represents a huge opportunity for healthcare providers and pharmaceutical companies.

Research Nester
Opioid Dependence Treatment Market Size
Get more information on this report: Request Free Sample PDF

Top Featuring Companies Dominating the Global Opioid Dependence Treatment Market

top-features-companies
    • Orexo AB
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Indivior PLC
    • Titan Pharmaceuticals, Inc.
    • Viatris Inc.
    • Pfizer, Inc.
    • Hikma Pharmaceuticals PLC
    • BioDelivery Sciences International Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alkermes
    • Camurus AB

In-the-news

In The News

  • May 2020- Orexo and Lyfebulb announced a partnership to help people struggling with alcohol and opioid use disorders in the times of the COVID-19 pandemic. 
  • November 2019- Indivior launched a direct-to-consumer advertising campaign for informing people about the additional treatment for opioid use disorder (OUD), which involves the use of a drug called SUBLOCADE.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4003
  • Published Date: May 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the market growth are the increasing number of cases of opioid abuse and addictions among people worldwide and favorable reimbursements for smoking cessation therapy.

The market size of opioid dependence treatment is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2035.

Side effects of opioid use disorder drugs are estimated to hamper the market growth.

North America is estimated to create notable growth opportunities for market growth over the forecast period.

The major players in the market are Orexo AB, Indivior PLC, Titan Pharmaceuticals, Inc., Viatris Inc., Pfizer, Inc., and Others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug class, sales channel, and region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Opioid Dependence Treatment Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying